Brand
Stason Pharmaceuticals, Inc.
1 federal recall on file. We monitor every CPSC, FDA, USDA, and NHTSA notice for Stason Pharmaceuticals, Inc. and translate it into plain English — free weekly digest, optional same-day alerts.
- 2024-03-13FDA-DrugClass IIIMercaptopurine Tablets, USP 50 mg, packaged in: a) 25-count bottle (NDC 69076-913-02), b) 250-count bottle (NDC 69076-913-25), Rx only, Manufactured for: Quinn Pharmaceuticals, Boca Raton, FL, www.quinnrx.com
Failed Dissolution Specifications: results slightly under spec at at 9-months.
Get notified about new Stason Pharmaceuticals, Inc. recalls
Free weekly digest. We email when a new federal recall affects Stason Pharmaceuticals, Inc. or anything else in your household.
Get the Sunday BriefExplore other recall topics
By hazard
By state